Hofseth BioCare ASA (HBCO.XC)

3.2800 -0.1200 (-3.53%) At close: 01:55PM BST

Hofseth BioCare ASA

Keiser Wilhelms gate 24
Ålesund 6003
Norway
47 73 10 22 00
https://www.hofsethbiocare.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 69

Description

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.

Corporate governance

Hofseth BioCare ASA’s ISS governance QualityScore as of 1 June 2024 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.